The content below is specific to Novartis Canada. To see all Novartis content, please visit the Novartis Global site.
News Archive
News Archive Navigation
icon
Showing 39 results
June 2020
-
Media ReleaseStatement from Novartis on AVXS-101 filing with Health CanadaJune 18, 2020 – Dorval - Novartis Pharmaceuticals Canada Inc. is pleased to announce the filing of a marketing application to Health Canada for AVXS-101 (onasemnogene abeparvovec), known in the US…
-
Media ReleaseLong-term, relapse-free survival data for high-risk, stage III melanoma patients treated with Tafinlar® + Mekinist® following surgery presented at ASCO20More than half of patients with BRAF-mutated advanced melanoma treated with Tafinlar + Mekinist were alive and free of a relapse at five years1 Study conclusions drawn from the five-year follow-up…